Eli Lilly stock (LLY) has a tokenised version, LLYx, a blockchain based asset that represents Eli Lilly and Company shares. Each LLYx token is backed 1:1 by real Eli Lilly shares held in regulated custody. Eli Lilly and Company is a pharmaceutical company founded in 1876 and based in Indianapolis, Indiana. It develops medicines for diabetes, obesity, cancer, immunology and neuroscience, and is well known for the diabetes and weight loss treatments Mounjaro and Zepbound. Holding LLYx gives you indirect exposure to Eli Lilly shares, but it is not the same as owning the underlying shares and does not come with shareholder rights.